147 related articles for article (PubMed ID: 21307221)
1. High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma.
Dalagiorgou G; Vassilaki N; Foka P; Boumlic A; Kakkanas A; Kochlios E; Khalili S; Aslanoglou E; Veletza S; Orfanoudakis G; Vassilopoulos D; Hadziyannis SJ; Koskinas J; Mavromara P
J Gen Virol; 2011 Jun; 92(Pt 6):1343-1351. PubMed ID: 21307221
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis.
Kassela K; Karakasiliotis I; Charpantidis S; Koskinas J; Mylopoulou T; Mimidis K; Sarrazin C; Grammatikos G; Mavromara P
J Gen Virol; 2017 Jul; 98(7):1713-1719. PubMed ID: 28708052
[TBL] [Abstract][Full Text] [Related]
3. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
[TBL] [Abstract][Full Text] [Related]
4. Recombinant expression of the alternate reading frame protein (ARFP) of hepatitis C virus genotype 4a (HCV-4a) and detection of ARFP and anti-ARFP antibodies in HCV-infected patients.
Shehat MG; Bahey-El-Din M; Kassem MA; Farghaly FA; Abdul-Rahman MH; Fanaki NH
Arch Virol; 2015 Aug; 160(8):1939-52. PubMed ID: 26036563
[TBL] [Abstract][Full Text] [Related]
5. Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.
Budkowska A; Kakkanas A; Nerrienet E; Kalinina O; Maillard P; Horm SV; Dalagiorgou G; Vassilaki N; Georgopoulou U; Martinot M; Sall AA; Mavromara P
PLoS One; 2011 Jan; 6(1):e15871. PubMed ID: 21283512
[TBL] [Abstract][Full Text] [Related]
6. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
[TBL] [Abstract][Full Text] [Related]
7. Sero-reactivity to three distinct regions within the hepatitis C virus alternative reading frame protein (ARFP/core+1) in patients with chronic HCV genotype-3 infection.
Elsheikh MEA; McClure CP; Tarr AW; Irving WL
J Gen Virol; 2022 Mar; 103(3):. PubMed ID: 35230930
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
Watanabe Y; Harada S; Saito I; Miyamura T
Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
[TBL] [Abstract][Full Text] [Related]
9. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.
Walewski JL; Keller TR; Stump DD; Branch AD
RNA; 2001 May; 7(5):710-21. PubMed ID: 11350035
[TBL] [Abstract][Full Text] [Related]
11. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C Virus core+1/ARF Protein Modulates the Cyclin D1/pRb Pathway and Promotes Carcinogenesis.
Moustafa S; Karakasiliotis I; Mavromara P
J Virol; 2018 May; 92(9):. PubMed ID: 29444947
[TBL] [Abstract][Full Text] [Related]
13. Identification of immunogenic regions within the alternative reading frame protein of hepatitis C virus (genotype 3).
Qureshi H; Qazi R; Hamid S; Qureshi SA
Eur J Clin Microbiol Infect Dis; 2011 Sep; 30(9):1075-83. PubMed ID: 21318731
[TBL] [Abstract][Full Text] [Related]
14. Impact of SEN virus on immunoblot INNO-LIA HCV reactivity pattern and disease outcome in Egyptian hepatocellular carcinoma patients.
Alam El-Din HM; Abo-Shadi MA; Helal A
Egypt J Immunol; 2007; 14(1):1-10. PubMed ID: 18689276
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.
Weinig M; Hakim JG; Gudza I; Tobaiwa O
Trans R Soc Trop Med Hyg; 1997; 91(5):570-2. PubMed ID: 9463670
[TBL] [Abstract][Full Text] [Related]
16. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus alternative reading frame protein (ARFP): Production, features, and pathogenesis.
Mohamadi M; Azarbayjani K; Mozhgani SH; Bamdad T; Alamdary A; Nikoo HR; Hashempour T; Hedayat Yaghoobi M; Ajorloo M
J Med Virol; 2020 Dec; 92(12):2930-2937. PubMed ID: 32470157
[TBL] [Abstract][Full Text] [Related]
19. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti-HCV-positive patients.
Komatsu F; Takasaki K
Liver; 1999 Oct; 19(5):375-80. PubMed ID: 10533794
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea.
Park BC; Han BH; Ahn SY; Lee SW; Lee DH; Lee YN; Seo JH; Kim KW
J Viral Hepat; 1995; 2(4):195-202. PubMed ID: 7489347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
